Lipid hydroperoxides inhibit nitric oxide production in RAW264.7 macrophages

被引:33
作者
Huang, AN
Li, CF
Kao, RL
Stone, WL
机构
[1] E Tennessee State Univ, Quillen Dishner Coll Med, Dept Pediat & Physiol, Johnson City, TN 37614 USA
[2] E Tennessee State Univ, Quillen Dishner Coll Med, Dept Surg, Johnson City, TN 37614 USA
关键词
atherosclerosis; lipid hydroperoxides; lysophosphatidylcholine; nitric oxide; iNOS; oxidized low density lipoprotein; macrophages; free radicals;
D O I
10.1016/S0891-5849(98)00236-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of oxidatively modified low density lipoprotein (oxLDL) on atherogenesis may be partly mediated by alterations in the production of nitric oxide (NO) by vascular cells. Lipid hydroperoxides (LOOH) and lysophosphatidylcholine (lysoPC) are the major primary products of LDL oxidation. The purpose of this study was to characterize the effects of oxLDL, LOOK and lysoPC on NO production and the expression of inducible nitric oxide synthase (iNOS) gene in lipopolysaccharide (LPS) stimulated macrophages. LDL was oxidized using an ate-initiator 2,2'-azobis (2-amidinopropane) HCl (ABAP) and octadecadienoic acid was oxidized by Lipoxygenase to generate 13-hydroperoxyl octadecadienoic acid (13-HPODE). Our study showed that oxLDL markedly decreased the production of NO, the levels of iNOS protein and iNOS mRNA in LPS stimulated macrophages. The inhibition potential of oxLDL on NO production and iNOS gene expression depended on the levels of LOOK formed in oxLDL and was not due to oxLDL cytotoxicity. Furthermore, 13-HPODE markedly reduced NO production and iNOS protein levels, whereas lysoPC showed only slight reduction. The effects of 13-HPODE and lysoPC did not require an acetylated LDL carrier. Our results suggest that 13-HPODE is a much more potent inhibitor of NO production and iNOS gene expression than lysoPC in LPS stimulated RAW264.7 macrophages. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:526 / 537
页数:12
相关论文
共 56 条
[1]  
Aviram M, 1996, EUR J CLIN CHEM CLIN, V34, P599
[2]  
AVIRAM M, 1994, J LIPID RES, V35, P385
[3]   DEGRADATION OF CATIONIZED LOW-DENSITY LIPOPROTEIN AND REGULATION OF CHOLESTEROL-METABOLISM IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA FIBROBLASTS [J].
BASU, SK ;
GOLDSTEIN, JL ;
ANDERSON, RGW ;
BROWN, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (09) :3178-3182
[4]   NITRIC-OXIDE AND PROSTACYCLIN - DIVERGENCE OF INHIBITORY EFFECTS ON MONOCYTE CHEMOTAXIS AND ADHESION TO ENDOTHELIUM INVITRO [J].
BATH, PMW ;
HASSALL, DG ;
GLADWIN, AM ;
PALMER, RMJ ;
MARTIN, JF .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02) :254-260
[5]   EXTENSIVE NITRATION OF PROTEIN TYROSINES IN HUMAN ATHEROSCLEROSIS DETECTED BY IMMUNOHISTOCHEMISTRY [J].
BECKMANN, JS ;
YE, YZ ;
ANDERSON, PG ;
CHEN, J ;
ACCAVITTI, MA ;
TARPEY, MM ;
WHITE, CR ;
BECKMAN, JS .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1994, 375 (02) :81-88
[6]   The L-arginine-nitric oxide pathway: Role in atherosclerosis and therapeutic implications [J].
Boger, RH ;
BodeBoger, SM ;
Frolich, JC .
ATHEROSCLEROSIS, 1996, 127 (01) :1-11
[7]   ENHANCED LDL OXIDATION BY MURINE MACROPHAGE FOAM CELLS AND THEIR FAILURE TO SECRETE NITRIC-OXIDE [J].
BOLTON, EJ ;
JESSUP, W ;
STANLEY, KK ;
DEAN, RT .
ATHEROSCLEROSIS, 1994, 106 (02) :213-223
[8]  
Buttery LDK, 1996, LAB INVEST, V75, P77
[9]   TOXICITY OF OXYSTEROLS TO HUMAN MONOCYTE-MACROPHAGES [J].
CLARE, K ;
HARDWICK, SJ ;
CARPENTER, KLH ;
WEERATUNGE, N ;
MITCHINSON, MJ .
ATHEROSCLEROSIS, 1995, 118 (01) :67-75
[10]   IN-VITRO CELL INJURY BY OXIDIZED LOW-DENSITY-LIPOPROTEIN INVOLVES LIPID HYDROPEROXIDE-INDUCED FORMATION OF ALKOXYL, LIPID, AND PEROXYL RADICALS [J].
COFFEY, MD ;
COLE, RA ;
COLLES, SM ;
CHISOLM, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1866-1873